By Sheri Kasprzak
New York, Aug. 7 - Uni-Bio Science Group Ltd. completed a private placement for HK$270 million.
The company issued 108 million shares at HK$2.50 each to Chow Tai Fook Nominee Ltd.
The offering size represents 14.21% of the company's issued share capital, and the price per share is a 16.38% discount to the company's HK$2.99 closing stock price from Aug. 4.
Proceeds will be used for acquisition opportunities and for the establishment of manufacturing capabilities to develop a bioscience-related business. The rest will be used for working capital.
Based in Hong Kong, Uni-Bio Science is a biotech company that develops therapeutic peptides used to treat diabetes and other disorders.
| Issuer: | Uni-Bio Science Group Ltd.
|
| Issue: | Stock
|
| Amount: | HK$270 million
|
| Shares: | 108 million
|
| Price: | HK$2.50
|
| Warrants: | No
|
| Investor: | Chow Tai Fook Nominee Ltd.
|
| Settlement date: | Aug. 4
|
| Stock symbol: | Hong Kong: 690
|
| Stock price: | HK$2.99 at close Aug. 4
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
